Thursday, 18 December 2014
Last updated 14 hours ago
Mar 17 2014 | 7:37am ET
Hedge funds added 2.46% in February, according to the Hennessee Hedge Fund Index, trailing the 4.31% gain of the S&P 500.
The top performing strategies for the month were healthcare and biotech, up 4.14%; distressed, up 3.72%; and international, up 3.29%
The bottom three strategies for the month were short biased, down 2.34%; market neutral, down 0.02%; and convertible arbitrage, up 0.19%.
“Risk assets reversed course again in February as volatility, measured by the VIX, subsided and market enthusiasm was restored,” said Charles Gradante, Hennessee Group co-founder, in a statement. "Investors stepped back into the market after January’s selloff and shrugged off disappointing European PMI data, a continued decrease in bank lending and emerging market tensions.”
Equity long/short hedge funds were up 2.81% in February (3.13% year to date), arbitrage event/driven strategies were up 1.83% (2.50% YTD) and merger arbitrage strategies were up 1.81% (2.04% YTD).
Global macro funds gained 2.53% in February (0.47% YTD). Emerging funds were up 2.14% on the month (down 0.20% YTD). Macro funds rose 2.65% for the month of February (0.83% YTD).
Dec 1 2014 | 10:21am ET
As 2014 winds down, Northern Trust Hedge Fund Services executives took some time to share their outlook on trends facing the industry in 2015. Read more…
Jeff Sprecher was simply looking for a platform to trade energies when launching ICE 14 years ago but it has grown to reach the pinnacle of both the listed futures and equities world.